The Nevada National Board Professional Learning Institute | Enemark | Activity http://www.nationalboardinstitute.com/members/windadult6/activity/ Activity feed for Enemark. Fri, 23 May 2025 17:06:54 -0700 https://buddypress.org/?v=9.1.1 en-US 30 hourly 2 25bfed369f8316a4935d9e8573562799 Enemark posted an update: Porous-permeable structures with magnetohydrodynamics (MHD) […] http://www.nationalboardinstitute.com/activity/p/40122/ Thu, 06 Feb 2025 13:26:19 -0800 Porous-permeable structures with magnetohydrodynamics (MHD) flow have a lot of applications in various disciplines of engineering. Transport of ferro-fluid in magnetic field has attained more focus in recent years. In this work, an analysis is accomplished to investigate the MHD transport of in-compressible viscid ferro-fluid (electrically…[Read more]

]]> 0 0a81887d121b7325e784e322158f6259 Enemark posted an update: e diseases remains to be determined. To benchmark and […] http://www.nationalboardinstitute.com/activity/p/34040/ Thu, 30 Jan 2025 11:39:01 -0800 e diseases remains to be determined.

To benchmark and evaluate the clinical viability of novel analytical GPU-accelerated and CPU-based Monte Carlo (MC) dose-engines for spot-scanning intensity-modulated-proton-therapy (IMPT) towards the improvement of lung cancer treatment.

Nine patient cases were collected from the CNAO clinical…[Read more]

]]> 0 df8c9b3e5751929abc010d77ed39f490 Enemark posted an update: Uterine corpus endometrial carcinoma (UCEC) is a common […] http://www.nationalboardinstitute.com/activity/p/30108/ Tue, 28 Jan 2025 14:43:39 -0800 Uterine corpus endometrial carcinoma (UCEC) is a common malignancy worldwide developed in the female reproductive system, which can be life-threatening due to metastasis and poor prognosis. Deubiquitinating enzymes (DUBs) play key roles in ubiquitin-proteasome system. Avapritinib As a member of DUBs, the ubiquitin-specific protease 5 (USP5) has…[Read more]

]]> 0 88bf1409519a8809a43f44b1f7455208 Enemark became a registered member http://www.nationalboardinstitute.com/activity/p/30074/ Tue, 28 Jan 2025 14:40:51 -0800 0